Q2 2023 Holdings
Filed 2023-08-14 | 55 holdings | $2.2B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-09-06) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mink Therapeutics Inc | COM | 603693102 | $682.2K | 324,867 | 0.0% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $773.9K | 308,314 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $995.3K | 228,277 | 0.0% |
| Fibrogen Inc(FGENEUR)Call | COM | 31572Q808 | $2.1M | 764,700 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $2.4M | 2,086,704 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $3.2M | 1,022,892 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.5M | 108,450 | 0.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.6M | 678,360 | 0.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $5.9M | 499,400 | 0.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $7.0M | 2,837,818 | 0.3% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $8.5M | 300,300 | 0.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $9.2M | 1,644,021 | 0.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $9.5M | 503,100 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $9.6M | 1,099,192 | 0.4% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $10.3M | 17,973,464 | 0.5% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P101 | $10.6M | 2,041,670 | 0.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $10.7M | 1,951,580 | 0.5% |
| Morphic Hldg Inc | COM | 61775R105 | $12.4M | 216,752 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $13.9M | 7,720,688 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $14.1M | 1,697,415 | 0.7% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $16.7M | 1,773,409 | 0.8% |
| Prothena Corp PLC(PRTA)Put | SHS | G72800108 | $17.1M | 250,000 | 0.8% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $18.8M | 1,004,561 | 0.9% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $18.8M | 3,916,361 | 0.9% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $19.3M | 1,451,201 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $20.7M | 2,523,000 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $21.3M | 2,750,000 | 1.0% |
| Point Biopharma Global Inc | COM | 730541109 | $25.2M | 2,781,565 | 1.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $27.6M | 384,200 | 1.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $27.7M | 514,021 | 1.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $28.1M | 2,499,912 | 1.3% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $28.4M | 3,453,744 | 1.3% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $28.9M | 2,727,606 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $29.9M | 2,997,830 | 1.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $30.4M | 1,279,502 | 1.4% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $34.1M | 835,446 | 1.6% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $35.7M | 15,000,000 | 1.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $42.1M | 1,317,316 | 1.9% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $48.0M | 30,000,000 | 2.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $50.2M | 2,778,107 | 2.3% |
| Guardant Health Inc(GH) | COM | 40131M109 | $53.7M | 1,500,000 | 2.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $67.4M | 3,187,415 | 3.1% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $71.9M | 2,819,045 | 3.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $73.4M | 4,050,000 | 3.4% |
| Geron Corp(GERN) | COM | 374163103 | $77.6M | 24,170,966 | 3.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $84.7M | 6,557,816 | 3.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $93.0M | 3,546,435 | 4.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $93.9M | 3,000,000 | 4.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $98.0M | 1,548,252 | 4.5% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $102.8M | 5,421,330 | 4.8% |